Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Blood Advances
|
January 4, 2018
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, et al.
Haematologica
|
April 17, 2025
Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma
Ingrid Quist-Lokken, Mira Tilseth, Clara Andersson-Rusch, et al.
Plos One
|
March 14, 2015
Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells
Kamila Anna Zub, Mirta Mittelstedt Leal de Sousa, Antonio Sarno, et al.
Genes, Chromosomes & Cancer
|
June 17, 2016
VOLIN and KJON-Two novel hyperdiploid myeloma cell lines
Thea Kristin Våtsveen, Magne Børset, Aida Dikic, et al.
Immunity, Inflammation and Disease
|
June 2, 2015
The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma
Anne M Sponaas, Siv H Moen, Nina B Liabakk, et al.
Haematologica
|
April 8, 2017
Monitoring multiple myeloma by quantification of recurrent mutations in serum
Even Holth Rustad, Eivind Coward, Emilie R Skytøen, et al.
Blood
|
October 16, 2007
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells
Unn-Merete Fagerli, Randi U Holt, Toril Holien, et al.
Blood
|
June 24, 2020
Monoclonal immunoglobulins promote bone loss in multiple myeloma
Marita Westhrin, Vlado Kovcic, Zejian Zhang, et al.
Journal of Medicinal Chemistry
|
March 4, 2015
Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics
Kwan-Young Jung, Huabo Wang, Peter Teriete, et al.
Oncotarget
|
October 17, 2015
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
Huabo Wang, Peter Teriete, Angela Hu, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Blood Advances
|
January 4, 2018
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, et al.
Haematologica
|
April 17, 2025
Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma
Ingrid Quist-Lokken, Mira Tilseth, Clara Andersson-Rusch, et al.
Plos One
|
March 14, 2015
Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells
Kamila Anna Zub, Mirta Mittelstedt Leal de Sousa, Antonio Sarno, et al.
Genes, Chromosomes & Cancer
|
June 17, 2016
VOLIN and KJON-Two novel hyperdiploid myeloma cell lines
Thea Kristin Våtsveen, Magne Børset, Aida Dikic, et al.
Immunity, Inflammation and Disease
|
June 2, 2015
The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma
Anne M Sponaas, Siv H Moen, Nina B Liabakk, et al.
Haematologica
|
April 8, 2017
Monitoring multiple myeloma by quantification of recurrent mutations in serum
Even Holth Rustad, Eivind Coward, Emilie R Skytøen, et al.
Blood
|
October 16, 2007
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells
Unn-Merete Fagerli, Randi U Holt, Toril Holien, et al.
Blood
|
June 24, 2020
Monoclonal immunoglobulins promote bone loss in multiple myeloma
Marita Westhrin, Vlado Kovcic, Zejian Zhang, et al.
Journal of Medicinal Chemistry
|
March 4, 2015
Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics
Kwan-Young Jung, Huabo Wang, Peter Teriete, et al.
Oncotarget
|
October 17, 2015
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
Huabo Wang, Peter Teriete, Angela Hu, et al.
Page
of 8